Stockreport

Celgene ups dose and enrollment in mid-stage study of bb2121 in multiple myeloma [Seeking Alpha]

CELGENE  (CELG) 
Last celgene earnings: 10/31 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.celgene.com
PDF Celgene ups dose and enrollment in mid-stage study of bb2121 in multiple myelomaCiting the totality of the clinical data, Celgene (NASDAQ:CELG) hasamended the protocol i [Read more]